|
Re: Tick tock
|
5
|
Resverlogix Corp.
|
Dec 13, 2018 10:31PM
|
|
Re: Phase 3 - Fall Start
|
5
|
Resverlogix Corp.
|
Jun 22, 2015 03:48PM
|
|
Re: Biogen vs. Resverlogix, CTAD December 5
|
5
|
Resverlogix Corp.
|
Nov 25, 2019 04:10PM
|
|
Re: FXR and liver transaminase related adverse events
|
5
|
Resverlogix Corp.
|
Oct 03, 2018 01:41PM
|
|
Re: You're right 10bagr, you didn't sway me....
|
5
|
Resverlogix Corp.
|
Feb 01, 2019 03:02PM
|
|
Re: Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE Trial
|
5
|
Resverlogix Corp.
|
Jul 25, 2017 09:59AM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
5
|
BIOASIS TECHNOLOGIES INC
|
Nov 23, 2018 03:44PM
|
|
New Zenith MD&A Posted on SEDAR
|
5
|
Zenith Epigenetics
|
Sep 27, 2017 03:44PM
|
|
Re: Happy Thanksgiving all....
|
5
|
Resverlogix Corp.
|
Oct 15, 2019 06:28AM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
5
|
Resverlogix Corp.
|
Nov 30, 2021 08:33AM
|
|
Re: New publication on ASSURE results
|
5
|
Resverlogix Corp.
|
Aug 30, 2018 10:12PM
|
|
Re: What If - Uses of Apabetalone
|
5
|
Resverlogix Corp.
|
Aug 12, 2018 02:35PM
|
|
Re: AGM Tuesday 12/12 1:30 PM MT
|
5
|
Resverlogix Corp.
|
Dec 12, 2017 09:49AM
|
|
What will Monday bring?
|
5
|
Resverlogix Corp.
|
Nov 06, 2015 02:19PM
|
|
Re: What would a success NR look like?
|
5
|
Resverlogix Corp.
|
Mar 30, 2019 03:20PM
|
|
Re: Tundup's message
|
5
|
Resverlogix Corp.
|
Apr 13, 2019 10:40AM
|
|
Re: HDL from an Alzheimer's disease perspective
|
5
|
Resverlogix Corp.
|
Jun 27, 2019 11:47AM
|
|
Re: Agm
|
5
|
Resverlogix Corp.
|
Oct 02, 2016 04:56PM
|
|
Re: Volume almost 100,000 at 11am
|
5
|
Resverlogix Corp.
|
Mar 13, 2019 11:55AM
|
|
Re: ZEN-3694/Enzalutamid... vs. Enzalutamide alone?
|
5
|
Zenith Epigenetics
|
Apr 08, 2018 10:52PM
|
